Research coauthored by RTI Health Solutions researchers will be presented at the 2022 World Symposium on Lysosomal Disease.
Clinical investigator perspectives on the effects of intrathecal idursulfase-lT treatment in children with neuronopathic mucopolysaccharidosis II. Yee KS, Alexanderian D, Hamm L, Martin S, Olayinka-Amao B, Whiteman DAH. Poster
